Europe Diagnostic Tests Market, By Type (Glucose Test, Infectious Diseases Test, Cytology Test, CBC Test, Blood Culture Test, Syphilis Test, Urea Test, C-Reactive Protein Test, Antigen Test, HBA1C Test, Pregnancy Test, Lipid Profile Test, Electrolytes Test, Liver Function Test, Stool Helicobacter Pylori Test, Calcium Test, Crossmatch Test, Thyroid Function Test, Stool Microscopy Test, Urine Microscopy Test, Unit Packed RBCS Test, ESR Test and Others Test), Solutions (Services and Products), Technology (Immunoassay-Based, PCR-Based, Next Gene Sequencing, Spectroscopy-Based, Chromatography-Based, Microfluidics, Substrate Technology and Others), Mode of Testing (Prescription-Based Testing and OTC Testing), Approach (Molecular Diagnostic Instrument, In-Vitro Diagnostic Instrument and Point Of Care Testing Instrument), Sample Type (Urine, Saliva, Blood, Hair, Sweat and Others), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Odontology and Others), Testing Type (Biochemistry, Haematology, Microbiology, Histopathology and Others), Age (Pediatric, Adult and Geriatric), End User (Hospitals, Diagnostic Center, Research Labs and Institutes, Research Institute, Homecare, Blood Banks, Specialty Clinics, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tenders, Retail Sales and Online Sales) – Industry Trends and Forecast to 2030.
Europe Diagnostic Tests Market Analysis and Size
According to the World Health Organization (WHO), chronic diseases will account for approximately 41 million deaths per year by April 2021, accounting for 71% of all fatalities. As a result, diagnostic tests have proven to be beneficial in the management of chronic illness conditions, as well as disease prevention, detection, and diagnosis. By identifying individual risk factors and early warning indicators, clinical diagnostics enable early prevention and intervention. As a result, as the prevalence of chronic illnesses rises, the overall market is expected to grow.
Data Bridge Market Research analyses that the diagnostic tests market, which was USD 160,573.05 million in 2022, is expected to reach USD 324678.67 million by 2030, at a CAGR of 9.2% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Europe Diagnostic Tests Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Glucose Test, Infectious Diseases Test, Cytology Test, CBC Test, Blood Culture Test, Syphilis Test, Urea Test, C-Reactive Protein Test, Antigen Test, HBA1C Test, Pregnancy Test, Lipid Profile Test, Electrolytes Test, Liver Function Test, Stool Helicobacter Pylori Test, Calcium Test, Crossmatch Test, Thyroid Function Test, Stool Microscopy Test, Urine Microscopy Test, Unit Packed RBCS Test, ESR Test and Others Test), Solutions (Services and Products), Technology (Immunoassay-Based, PCR-Based, Next Gene Sequencing, Spectroscopy-Based, Chromatography-Based, Microfluidics, Substrate Technology and Others), Mode of Testing (Prescription-Based Testing and OTC Testing), Approach (Molecular Diagnostic Instrument, In-Vitro Diagnostic Instrument and Point Of Care Testing Instrument), Sample Type (Urine, Saliva, Blood, Hair, Sweat and Others), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Odontology and Others), Testing Type (Biochemistry, Haematology, Microbiology, Histopathology and Others), Age (Pediatric, Adult and Geriatric), End User (Hospitals, Diagnostic Center, Research Labs and Institutes, Research Institute, Homecare, Blood Banks, Specialty Clinics, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tenders, Retail Sales and Online Sales)
|
|
Countries Covered
|
Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe
|
|
Market Players Covered
|
F-Hoffman La-Roche Ltd. (Switzerland), ABBOTT (U.S.), Danaher (U.S.), B.D. (U.S.), Thermo Fisher Scientific Inc. (U.S.), ACON Laboratories Inc. (U.S.), Hemosure, Inc. (U.S.), MicroGen Diagnostics (U.S.), QIAGEN (Germany), Grifols, S.A (Spain), BODITECH MED INC. (South Korea), Chembio Diagnostic Systems, Inc. (U.S.), Nanoentek (South Korea), DiaSorin S.p.A. (Italy), Bio-Rad Laboratories, Inc. (U.S.), BIOMEDOMICS INC (U.S.), EKF Diagnostics Holdings plc (U.K.), Siemens Healthcare GmbH (Germany), PerkinElmer Inc. (U.S.), BIOMÉRIEUX (France), ARKRAY USA, Inc. (U.S.), Biohit Oyj (Finland), Germaine Laboratories, Inc. (U.S.), Quidel Corporation (U.S.), Illumina, Inc. (U.S.), Lamdagen Corporation (U.S.), LifeSign LLC. (U.S.), Medixbiochemica (Finland), Nova Biomedical (U.S.), Ortho Clinical Diagnostics (U.S.), Sannuo Biosensing Co., Ltd. (U.S.), STRECK (U.S.), Sysmex Corporation (Japan), among others
|
|
Market Opportunities
|
|
Market Definition
Diagnostic tests are medical procedures used to aid in the detection or diagnosis of disease. These tests play an important role in disease control, surveillance, and prevention. These tests aid in the enhancement of patient care, consumer safety, and healthcare spending. A diagnostic test is one that is used to figure out what is causing a condition. A diagnostic test performed as part of a medical examination may be used to identify a disease or to determine the cause of symptoms. When used for other purposes, a diagnostic test can be used to identify specific strengths and weaknesses.
Europe Diagnostic Tests Market Dynamics
Drivers
- Growing incidences of infectious and chronic diseases
Infectious diseases and chronic conditions are putting a strain on the global population. Infectious diseases like diphtheria, ebola, flu, hepatitis, HIV/AIDS, HPV, tuberculosis, and others are caused by microorganisms, and sudden outbreaks like dengue, Zika virus, COVID-19, and Swine flu drive international demand for clinical diagnostic tests. Furthermore, chronic diseases such as cancer, diabetes, cardiovascular disease, obesity, and others are driving up demand for clinical diagnostics.
- Rising clinical diagnostic tests
The most accurate techniques for identifying and describing microorganisms are clinical diagnostic tests. A practical test needs to be quick, precise, and able to identify the infection's severity. The time it takes to locate the proper antibiotic is decreased through faster, more accurate testing that identifies the strain of the organism and its medication susceptibility. According to a World Health Organization (WHO) report, tuberculosis (TB) was one of the top ten causes of death. This will probably have a big impact on market expansion. The rising prevalence of cancer cases in living standards can be largely attributed to the accessibility and availability of better diagnostic techniques. Because clinical cancer diagnostics equipment is widely used in these procedures, demand for diagnostic tests rises during the forecast period.
Opportunities
- Growing demand for advanced diagnostic solutions
Clinical diagnostics are used to manage patients' health. It allows for the earlier detection of diseases and aids in the progression of illnesses. Furthermore, it may aid infected individuals in avoiding long-term consequences, raising public awareness of the significance of clinical diagnosis. Increased healthcare spending and health awareness encourage market growth. As people grow more concerned about the possibility of disease transmission from infected patients, the demand for clinical diagnostic kits is anticipated to increase during the forecast period. Diagnostic testing can be carried out using services as well as equipment and supplies. This feature will almost certainly improve patient comfort, which will benefit the market.
Restraints/Challenges
- Affordability for diagnostics tests
Pricing pressures from reimbursement cuts and budget constraints, along with stringent regulatory policies, are expected to hamper market growth. Furthermore, the diagnostic tests market is expected to be challenged by a lack of alignment with definitive central lab methods and insufficient adoption of POC devices in professional settings during the forecast period of 2023-2030.
This diagnostic tests market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the diagnostic tests market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Diagnostic Tests Market
COVID-19 has negatively impacted the diagnostic test market because lab testing has increased, causing demand to rise even faster to keep up with suspected COVID-19 cases. According to the Atlantic Monthly Group, the number of COVID-19 tests worldwide increased dramatically from 760,441 in September 2020 to 964,792 in October 2020. As a result, the rising number of tests due to increased patient numbers and government funding is expected to drive demand for COVID-19 test kits and fuel the overall market's exponential growth.
Recent Developments
- In 2020, Siemens Healthcare GmbH officially announced the release of the RAPIDPoint 500e Blood Gas Analyzer, which broadened the company's product portfolio and is also used in COVID-19 efforts. This helps to increase revenue from the line.
- In 2020, Siemens Healthcare GmbH and the Marienhaus Hospital Group have announced a ten-year collaboration. This collaboration will benefit the company in diagnostics in the long run. This agreement will also help the company's financial situation.
Europe Diagnostic Tests Market Scope
The diagnostic tests market is segmented on the basis of type, solution, technology, mode of testing, approach, sample type, application, testing type, age, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Glucose Test
- Infectious Diseases Test
- Cytology Test
- CBC Test
- Blood Culture Test
- Syphilis Test
- Urea Test
- C-Reactive Protein Test
- Antigen Test
- HBA1C Test
- Pregnancy Test
- Lipid Profile Test
- Electrolytes Test
- Liver Function Test
- Stool Helicobacter Pylori Test
- Calcium Test, Crossmatch Test
- Thyroid Function Test
- Stool Microscopy Test
- Urine Microscopy Test
- Unit Packed Rbcs Test
- ESR Test and Others Test
Solutions
- Services
- Products
Technology
- Immunoassay-Based
- PCR-Based
- Next Gene Sequencing
- Spectroscopy-Based
- Chromatography-Based
- Microfluidics
- Substrate Technology
- Others
Mode of Testing
- Prescription-Based Testing
- OTC Testing
Approach
- Molecular Diagnostic Instrument
- In-Vitro Diagnostic Instrument
- Point of Care Testing Instrument
Sample Type
- Urine
- Saliva
- Blood
- Hair
- Sweat
- Others
Application
- Cardiology
- Oncology
- Neurology
- Orthopedics
- Gastroenterology
- Gynecology
- Odontology
- Others
Testing Type
- Biochemistry
- Hematology
- Microbiology
- Histopathology
- Others
Age
- Pediatric
- Adult
- Geriatric
End User
- Hospitals
- Diagnostic Center
- Research Labs and Institutes
- Research Institute
- Homecare
- Blood Banks
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
Distribution Channel
- Direct Tenders
- Retail Sales
- Online Sales
Europe Diagnostic Tests Market Regional Analysis/Insights
The diagnostic tests market is analyzed and market size insights and trends are provided by country, type, solution, technology, mode of testing, approach, sample type, application, testing type, age, end user and distribution channel as referenced above.
The countries covered in the diagnostic tests market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
Germany is dominating the Europe diagnostic tests market to government strategic initiatives such as acquisition and focused segment product launches, which are assisting them to expand their reach and also assisting them to expand and enhance the company's product portfolio, which will ultimately lead to more revenue generation in the country.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Diagnostic Tests Market Share Analysis
The diagnostic tests market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to diagnostic tests market.
Some of the major players operating in the diagnostic tests market are:
- F-Hoffman La-Roche Ltd. (Switzerland)
- ABBOTT (U.S.)
- Danaher (U.S.)
- B.D. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- ACON Laboratories Inc. (U.S.)
- Hemosure, Inc. (U.S.)
- MicroGen Diagnostics (U.S.)
- QIAGEN (Germany)
- Grifols, S.A (Spain)
- BODITECH MED INC. (South Korea)
- Chembio Diagnostic Systems, Inc. (U.S.)
- Nanoentek (South Korea)
- DiaSorin S.p.A. (Italy)
- Bio-Rad Laboratories, Inc. (U.S.)
- BIOMEDOMICS INC (U.S.)
- EKF Diagnostics Holdings plc (U.K.)
- Siemens Healthcare GmbH (Germany)
- PerkinElmer Inc. (U.S.)
- BIOMÉRIEUX (France)
- ARKRAY USA, Inc. (U.S.)
- Biohit Oyj (Finland)
- Germaine Laboratories, Inc. (U.S.)
- Quidel Corporation (U.S.)
- Illumina, Inc. (U.S.)
- Lamdagen Corporation (U.S.)
- LifeSign LLC. (U.S.)
- Medixbiochemica (Finland)
- Nova Biomedical (U.S.)
- Ortho Clinical Diagnostics (U.S.)
- Sannuo Biosensing Co., Ltd. (U.S.)
- STRECK (U.S.)
- Sysmex Corporation (Japan)
SKU-